Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



4 Hot Stock Tips

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

Odds are, you clicked into this article hoping for some stocks that will propel your portfolio to new heights. I'm sorry, but those aren't the kinds of tips I'm offering. But don't be disappointed, because the tips I do have for you can do much more for your portfolio over the rest of your investing life.

Beware of hot stock tips
That's right -- the first hot stock tip is to be wary whenever presented with anything called "hot stock tips." Take responsibility for your own investment decisions, and dig into any stock tips to determine for yourself whether you like what you see. If the stocks have been guaranteed to perform spectacularly, consider running for the hills. There are few guarantees in the stock market, and promises of short-term riches are big red flags.

Don't focus on absolute price
The price of a share of stock in a company is not very meaningful without some context. Too often, people get excited by penny stocks (which are notoriously risky) because they think that being able to buy 3,000 shares of a $1 stock is better than buying 30 shares of a $100 stock. It's not. A $100 stock can become a $200, $300, or $1,000 one, and a $1 stock will often become a $0.50 one.

To draw meaning from a stock's price, compare it with earnings, or dividend amounts, or some other measure. Divide a company's annual dividend amount by its stock price, for example, and you'll get its dividend yield, which will permit you to compare corporate payouts in a more apples-to-apples fashion. Consider, for example, pharmaceutical giant AbbVie, the result of a separation from Abbott Labs, and tobacco-and-real-estate specialist Vector Group. Each was recently paying out $0.40 in dividends quarterly, for an annual total of $1.60. But since AbbVie has been trading around $44 per share and Vector around $16, their dividend yields are quite different, recently about 3.6% for AbbVie and 10.1% for Vector.

Don't overpay
You do want to find great companies in which to invest, but you don't want to pay too much for them. One rough method of assessing how expensive or inexpensive a stock is involves comparing its price with its earnings per share and arriving at its P/E ratio. This can also help you see how seemingly high-priced stocks can actually be more attractive than lower-priced ones.

Shares of specialty insurer Markel, for example, recently traded around $530 per share, and sported a P/E ratio near 18. Burger King Worldwide, with a share price around $19, may seem "cheaper" and thus more attractive, but its P/E ratio recently approached 50. It costs you far more per dollar of earnings than Markel does.

When you're considering any stock for your portfolio, aim to buy only when it seems to be a bargain. That's a stock tip that can help you focus on companies with the best chance of growing.

Don't think it's too early or late to invest
Here's another vital tip: Don't put off or give up on the idea of investing for the long term. Sure, you might be 67 already, but you may well live to be 87 or 97, giving you 20 or 30 years in which you could be enjoying growth in the stock market. Meanwhile, if you're 25, or even just 15, think twice before you put off investing. Check out how powerful time can be in the table below. I'll model growth at 10%, which is roughly the stock market's long-term average annual gain, and I'll also model 3%, to demonstrate the power of time on modest growth rates:

$1,000 grows...

At 3%

At 10%

For 10 years



For 20 years



For 30 years



For 40 years



For 50 years



For 60 years



With whatever companies you consider for your portfolio, be sure to keep the stock tips above in mind.

More investing advice from The Motley Fool
In the pharma business, great success comes with a caveat. AbbVie is a perfect example, as investors in the new company are left wondering what the future holds once the company's golden goose, Humira, is cooked. The Fool's premium report on the company answers the high-profile questions that AbbVie investors are asking. Simply click here now to claim your copy today.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2420111, ~/Articles/ArticleHandler.aspx, 9/27/2016 11:46:16 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 2 hours ago Sponsored by:
DOW 18,228.30 133.47 0.74%
S&P 500 2,159.93 13.83 0.64%
NASD 5,305.71 48.22 0.92%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes